Board Change

London, 26 June 2014: NMC Health Plc (LSE:NMC / 'NMC'), the leading integrated private sector healthcare operator in the United Arab Emirates, is pleased to announce the appointment of Mr Keyur Nagori as a Non-Executive Director of NMC with immediate effect.

Appointment of Non-Executive Director

NMC announces the appointment of Mr Keyur Nagori as a Non-Executive Director of the Company.

Mr Nagori has a background working in International audit firms including Deloitte and KPMG for over 10 years. During this time he had significant experience in the audit of multinational and local companies in both India and Abu Dhabi.

For the last 10 years, he has been working within the finance department of KBBO Group based in Abu Dhabi and he is currently Chief Financial Officer of KBBO Group.

Mr Nagori was an Alternate Director to the Company's previous Director, H.E. Saeed Bin Butti, from 27 June 2013 to 24 February 2014.

Mr Nagori joins the board alongside Mrs Salma Hareb, Dr Ayesha Abdullah, Dr Nandini Tandon, Mr Binay Shetty and Mr Prasanth Manghat who were each appointed to the Board by NMC's shareholders at today's AGM.

There is no additional information in respect of Mr Nagori which is required to be notified for the purpose of Listing Rule 9.6.13.

Contacts

Investors:

Roy Cherry, Head of Strategy and Investor Relations +971 50 667 0184

Media:

Brunswick London

Justine McIlroy/Azadeh Varzi

+44 20 7404 5959

Brunswick Gulf

Steve Martin Wajih Halawa

+971 5 6696 9232 +971 5 0100 9207

About NMC

NMC Health plc group is the leading integrated private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Healthcare division currently operates or manages five hospitals, two day-care patient centres, one medical centre and eight pharmacies. The company received 2.1m patients in 2013. The group also operates a significant UAE wide Distribution business supplying product lines across several key market segments, including: Pharmaceutical, FMCG, Food and Scientific and Medical Equipment. NMC Health plc group reported revenues of US$ 550.9m in 2013.

In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange. At the time of its IPO, the group raised funds to enable it to pursue a further growth plan with a number of capital projects for new healthcare facilities in Abu Dhabi and Dubai. NMC Health plc is a constituent of the FTSE 250 Index.